Related Experiment Videos

Birth weight and stages of CKD: a case-control study in an Australian population

Isa Al Salmi1, Wendy E Hoy, Srinivas Kondalsamy-Chennakes

  • 1Centre for Chronic Disease, The University of Queensland, Brisbane, QLD, Australia. i.alsalmi@uq.edu.au

Insights

Lower birth weight in Australian adults is linked to a higher risk and progression of chronic kidney disease (CKD). This association was observed across all stages of CKD, particularly in advanced cases.

Area of Science:

  • Nephrology
  • Epidemiology
  • Public Health

Background:

  • Recent studies suggest a link between birth weight and kidney disease.
  • Investigating the relationship between birth weight and chronic kidney disease (CKD) in Australian adults is crucial.

Purpose of the Study:

  • To evaluate the association between birth weight and the prevalence and progression of chronic kidney disease (CKD) in Australian adults.
  • To determine if lower birth weight is a risk factor for developing CKD.

Main Methods:

  • A case-control study was conducted with 189 CKD patients and matched controls from the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study.
  • Participants recalled their birth weight; CKD staging used the National Kidney Foundation-Kidney Disease Outcomes Quality Initiative classification.

Main Results:

  • CKD patients had significantly lower mean birth weights (3.27 kg) compared to controls (3.46 kg).
  • A higher proportion of CKD patients (12.2%) had birth weights below 2.5 kg versus controls (4.4%).
  • Lower birth weights were strongly associated with more advanced stages of CKD, especially stage 5 (P < 0.001).

Conclusions:

  • Lower birth weight is a potential predisposing factor for CKD and its progression in Australian adults.
  • The association between birth weight and CKD may be related to nephron number, a known factor influenced by birth weight.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...